CANC ETF: Tema Oncology ETF - Price, Holdings & Analysis
Tema Oncology ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About Tema Oncology ETF
What is the current price of CANC?
The latest CANC price is $41.44. The 52-week range is $25.12–$42.63. CANC has returned 53.0% over the past 52 weeks.
What is the expense ratio for CANC?
CANC's annual expense ratio is 0.75%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does CANC pay dividends?
Yes, CANC pays a 0.05% dividend yield. The last ex-dividend date was 2026-12-11. View full dividend history in the Dividends section.
What are the top holdings of CANC?
CANC's largest holdings are Revolution Medicines, Inc (7.2%), Eli Lilly and Company (5.3%), Legend Biotech Corporation (4.7%) (combined weight: 17.2%). The fund holds 60 total positions. View the complete portfolio breakdown in the Holdings section.
How does CANC compare to similar ETFs?
Compare CANC (0.75% expense ratio, $178M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.